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Functional avidityVirus-speciﬁc T cell responses are often directed to a small subset of possible epitopes and their relative
magnitude deﬁnes their hierarchy. We determined the size and functional avidity of 4 representative
peptide-speciﬁc CD8+ T cell populations in C57BL/6 mice at different time points after lymphocytic
choriomeningitis virus (LCMV) infection. We found that the frequency of different peptide-speciﬁc T cell
populations in the spleen changed independently over the ﬁrst 8 days after infection. These changes were not
associated with a larger or more rapid increase in functional avidity and yet still resulted in a shift in the ﬁnal
immunodominance hierarchy. Thus, the immunodominance observed at the peak of an antiviral T cell
response is not necessarily determined by the initial size or rate of functional avidity maturation of peptide-
speciﬁc T cell populations.
© 2009 Elsevier Inc. All rights reserved.IntroductionAlthough a pathogen may encode a large number of potential
peptides that can bind major histocompatibility complex class I (MHC
Class I) molecules, often only a limited number of peptide antigens are
recognized by CD8+ T cells (Chen and McCluskey, 2006; Yewdell and
Bennink, 1999). These CD8+ T cell responses can be ranked by the size
of each peptide-speciﬁc CD8+ T cell population to deﬁne an
immunodominance hierarchy. Strong T cell responses are deﬁned as
dominant, whereas weak responses are considered subdominant.
Multiple factors determine the immunodominance hierarchy and
elucidation of these factors is important in the design of effective
vaccines, which should induce T cell responses to a broad array of
antigens in order to prevent escape of a pathogen by mutation of any
single epitope (Phillips et al., 1991; Pircher et al., 1990). Studies have
shown that the formation of immunodominance hierarchies can be
inﬂuenced or associated with changes in antigen processing and
transport (Chen et al., 2000; Crowe et al., 2003), the afﬁnity of the
peptide for MHC (Chen et al., 2000; van der Most et al., 1997), the
avidity of the TcR for peptide:MHC (Zehn et al., 2009), the size (Butz
and Bevan, 1998; Choi et al., 2002; Obar et al., 2008) and repertoire
(Daly et al., 1995) of the precursor T cell population, and competition
between Tcell populations (Brehm et al., 2002; Rodriguez et al., 2002)
with cytokines such as IFNγ appearing to play an early role in this
process (Liu et al., 2004; Rodriguez et al., 2002). Thus, it is likely that
most immunodominance hierarchies are determined by the combined
impact of several independent factors.ll rights reserved.Lymphocytic choriomeningitis virus (LCMV) infection of mice is an
established model for the study of antiviral CD8+ T cell responses
(Buchmeier and Zajac, 1999; Oldstone 2002). The infection is typically
asymptomatic but results in strong antiviral T cell responses that can
be monitored directly ex vivo using intracellular cytokine staining
after peptide stimulation (Homann et al., 2001; Murali-Krishna et al.,
1998; Slifka andWhitton, 2001). LCMV-speciﬁc Tcell responses can be
detected as early as 3 days after infection (Homann et al., 2001;
Murali-Krishna et al., 1998) and peak by 7–8 days after infection
(Homann et al., 2001; Murali-Krishna et al., 1998; Raue and Slifka,
2007) after which the response declines by 10- to 20-fold before
reaching a stable memory phase (Grayson et al., 2002; Homann et al.,
2001; Murali-Krishna et al., 1998; Raue and Slifka, 2007; Tebo et al.,
2005). CD8+ T cells from LCMV-infected BALB/c mice recognize
several peptide epitopes (NP118, NP313, GP99, GP283)with 90–95% of
LCMV-speciﬁc CD8+ T cells focused on the immunodominant peptide,
NP118 (van der Most et al., 1997; van der Most et al., 1998). NP118-
speciﬁc CD8+ Tcells increase their sensitivity to peptide antigen by up
to 80-fold (Slifka and Whitton, 2001) in a process described as
functional avidity maturation. CD8+ T cells from LCMV-infected
C57BL/6 mice recognize up to 28 different peptides (Kotturi et al.,
2007). CD8+ T cells speciﬁc for two peptides, NP396 and GP33/34 (a
peptide presented by H-2Db and H-2Kb), dominate the response with
the remainder of the antiviral CD8+ T cells representing either
intermediate or subdominant T cell responses. In this study, we
selected 4 representative peptides (NP396, GP33/34, GP276, NP205)
recognized by CD8+ T cells from LCMV-infected C57BL/6 mice and
evaluated themagnitude and functional avidity of the peptide-speciﬁc
responses in the spleen at early and late time points after infection
using direct ex vivo peptide stimulation and intracellular cytokine
Fig. 1. Evolution of splenic CD8+ Tcell immunodominance during acute LCMV infection.
The immunodominance hierarchy of representative virus-speciﬁc CD8+ Tcell responses
were examined in the spleen at time points ranging from 4.5 days to 315 days after
LCMV infection. CD8+ T cells were stimulated with 1×10−4 M peptide (GP33/34,
NP396, GP276, or NP205) in the presence of brefeldin A for 6 h directly ex vivo and
peptide-speciﬁc responses were measured by intracellular staining for IFNγ. Similar
results were observed when 1×10−5 M peptide was used for stimulation (data not
shown). The graphs show the average±standard deviation for each peptide-speciﬁc
response at the time points indicated. Data represent 3–6 mice per group from 3 to 5
independent experiments.
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frequency of the peptide-speciﬁc CD8+ Tcell populations resulted in a
previously unrealized but reproducible shift in the immunodomi-
nance hierarchy. This result was unrelated to changes in the functional
avidity of the individual CD8+ T cell responses and, notably, not all T
cell populations underwent extensive functional avidity maturation.
Moreover, the early shift in immunodominance indicates that the ﬁnal
immunodominance hierarchy evolves rapidly during acute infection
and is not strictly determined by the size of the precursor T cell
populations.
Results
Immunodominance after LCMV infection
We assessed the immunodominance hierarchy of GP33/34-,
NP396-, GP276- and NP205-speciﬁc CD8+ T cells at different time
points after infection with LCMV-Armstrong using direct ex vivo
peptide stimulation followed by intracellular cytokine staining for
IFNγ (Fig. 1). Initially (day 4.5), the combined GP33/34-speciﬁc T
cell response was approximately 2-fold greater than the NP396-
speciﬁc T cell response. This might be expected since the naïve T
cell precursor frequency for GP33/H-2Db is estimated to be about
twice the size of the naïve NP396/H-2Db-speciﬁc CD8+ T cell
population (Obar et al., 2008). The frequency of each peptide-
speciﬁc CD8+ T cell response in the infected spleen approximately
doubled between 4.5 and 5 days after infection, consistent with the
rapid proliferation rates observed during the early stages of LCMV
infection (Homann et al., 2001; Murali-Krishna et al., 1998). In
contrast, between 5 and 8 days after infection the expansion of
these responses was no longer synchronized, resulting in a gradual
shift in the immunodominance hierarchy. The NP396-speciﬁc T cell
response was subdominant to the combined GP33/34-speciﬁc
response in 100% (12/12) of mice examined between 4.5 and
6 days post-infection. This indicates that although the difference in
immunodominance is not large, it is highly consistent. At 8 days
post-infection however, the NP396-speciﬁc T cell response moved
from intermediate dominance (i.e., higher than GP276 and NP205,
but lower than GP33/34) to the expected codominant position with
the GP33/34-speciﬁc response (Murali-Krishna et al., 1998). The
combined GP33/34-speciﬁc T cell to NP396-speciﬁc T cell ratio
shifted signiﬁcantly from 2.0±0.24 at 4.5 days post-infection to 1.2
±0.17 (i.e., codominant) at 8 days post-infection (P=0.002).
During the memory phase (N60 days post-infection), the NP396-
speciﬁc T cell response maintained codominance with GP33/34-
speciﬁc T cell responses or demonstrated a slightly higher
frequency than their GP33/34-speciﬁc counterpart in 10/14 (71%)
of the animals examined.
The shift in immunodominance was even more dramatic between
the subdominant T cell populations speciﬁc for NP205 and GP276,
which switched positions within the hierarchy during the ﬁrst 8 days
after LCMV infection. The NP205-speciﬁc response was 3-fold higher
than the GP276-speciﬁc response at 4.5 and 5 days after infection (Fig.
1) but lost its dominant position over GP276 by 8 days post-infection.
Accordingly, the GP276-speciﬁc T cell to NP205-speciﬁc T cell
frequencies shifted from a ratio of 0.29±0.37 to 1.4±0.55 between
day 4.5 and day 8 post-infection, respectively (P=0.003). At later
time points during the memory phase, the GP276-speciﬁc T cell
response became even more dominant, with a frequency that was
about 3-fold higher than that observed with NP205-speciﬁc T cell
populations. LCMV-speciﬁc CD8+ T cell responses declined between 8
and 15 days post-infection and then remained stable for at least
315 days after infection (Homann et al., 2001; Murali-Krishna et al.,
1998). The rapid evolution of the immunodominance hierarchy
observed in the spleen during acute LCMV infection indicates that
the size of the peptide-speciﬁc CD8+ T cell populations identiﬁed
Fig. 2. Functional avidity maturation of splenic CD8+ T cells after LCMV infection. (a)
Analysis of functional avidity was performed at the indicated time points after LCMV
infection by stimulating T cells with graded doses of GP33/34, NP396, GP276, or NP205
peptide. Peptide-speciﬁc CD8+ T cell responses were measured using intracellular
staining for IFNγ and expressed as a percentage of the maximum response attained
with saturating peptide concentrations (1×10−4 M). (b) To normalize the rates of
functional avidity maturation among different peptide-speciﬁc T cell populations, the
peptide concentration at which 50%maximum responsewas reached at each time point
was calculated by linear interpolation and expressed relative to the peptide
concentration at which 50% maximum response was reached by the earliest T cells
measured at 4.5 days after LCMV infection. The data show the average of 3–6 mice per
group from 3 to 5 independent experiments.
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determine the eventual immunodominance hierarchy observed
during the peak or memory phase of the virus-speciﬁc T cell response.
Functional avidity after infection with LCMV
To assess changes in the functional avidity of the peptide-speciﬁc
T cell responses, CD8+ T cells obtained at the indicated time points
after LCMV infection were stimulated with graded doses of peptide
antigen. After stimulation, the magnitude of the CD8+ T cell
response at each concentration of peptide was measured using
intracellular staining for IFNγ and is expressed as a percentage of
the maximum response observed after stimulation with 1×10−4 M
peptide (Fig. 2a). To determine the magnitude of functional avidity
maturation, the concentration of peptide at which 50% of the
maximal response was reached was calculated by linear interpola-
tion and normalized to the fold increase over the average functional
avidity observed at 4.5 days after infection (Fig. 2b). Between 4.5
and 6 days after infection, the functional avidity of the combined
GP33/34-speciﬁc response increased by about 4-fold whereas the
GP276-speciﬁc response showed no observable improvement in
peptide sensitivity. In sharp contrast, the NP-speciﬁc T cell responses
were much more dynamic. NP396-speciﬁc T cells demonstrated a
10- to 11-fold increase in functional avidity between 4.5 and 8 days
post-infection and peptide sensitivity improved further, with an 80-
to 130-fold improvement in functional avidity noted during the
memory phase of the response. The functional avidity of NP205-
speciﬁc CD8+ T cells increased by approximately 30-fold during the
acute phase of infection and remained stable for N300 days after
infection. Despite their rapid and substantial increase in functional
avidity, NP205-speciﬁc T cells remained a subdominant T cell
population. In contrast, despite only minor changes in functional
avidity, GP33/34-speciﬁc T cells maintained their immunodominant
status. Comparison of immunodominance proﬁles (Fig. 1) and
changes in functional avidity (Fig. 2) indicated that the immuno-
dominance hierarchy of virus-speciﬁc CD8+ T cells is not necessarily
determined by changes in peptide sensitivity during the course of
acute LCMV infection.
Role of CD8 engagement in T cell activation
Engagement of the CD8 coreceptor by MHC Class I is important for
CD8+ T cell activation (Bachmann et al., 1999; Purbhoo et al., 2001;
Slifka and Whitton, 2001; Viola et al., 1997) and we have previously
shown that high functional avidity correlates with resistance to
blockade of CD8/MHC Class I interactions by NP118-speciﬁc T cells
from LCMV-infected BALB/c mice (Slifka and Whitton, 2001). To
determine if similar results would be found in LCMV-infected C57BL/6
mice, CD8+ T cells obtained at 5 or 8 days post-LCMV infection
(representing low functional avidity or high functional avidity T cell
populations, respectively) were stimulated with 1×10−5 M GP33/34
or NP396 peptide in the presence or absence of graded doses of anti-
CD8 blocking antibody. The magnitude of the response at each
concentration of anti-CD8was determined by intracellular staining for
IFNγ and expressed as a percentage of the response observed in the
absence of anti-CD8 blockade (Fig. 3a). Low concentrations (e.g.,
0.1 μg/ml) of anti-CD8 antibody had little or no effect on GP33/34-
speciﬁc (Fig. 3b) or NP396-speciﬁc (Fig. 3c) CD8+ T cells. In contrast,
higher concentrations of blocking antibody signiﬁcantly inhibited T
cells with a low relative functional avidity phenotype (day 5)
compared with T cells of the same peptide speciﬁcity that had a
higher functional avidity phenotype (day 8). The magnitude of the
differences in resistance to anti-CD8 blocking antibody reﬂected the
fold-differences in functional avidity; GP33/34-speciﬁc responses
underwent less avidity maturation between day 5 and day 8 post-
infection (Fig. 2) and demonstrated comparatively smaller (but stillstatistically signiﬁcant) differences in resistance to anti-CD8 blocking
antibody. In contrast, NP396-speciﬁc T cells underwent a larger
change in functional avidity maturation between 5 and 8 days post-
infection and likewise showed a larger difference in resistance to anti-
CD8 blockade. The ratio of CD8α/CD8β expression may also be
associated with changes in functional avidity (Kroger and Alexander-
Miller, 2007b) but we did not ﬁnd consistent differences in CD8α/
CD8β expression that were predictive of higher functional avidity, at
Fig. 3. High functional avidity correlates with resistance to anti-CD8 blockade. To
determine the requirement for CD8 coreceptor binding during peptide recognition and
Tcell activation,CD8+Tcells obtained at5 or8dayspost-LCMV infection (representing low
and high functional avidity populations, respectively) were stimulated with 1×10−5 M
NP396 or GP33/34 in the presence of graded doses (10–0.1 μg/ml) of anti-CD8 blocking
antibodies. Antigen-speciﬁc Tcell responseswere quantiﬁed by intracellular staining for
IFNγ. (a) Representative dot plots show CD8+ T cell responses following stimulation
with NP396 after incubation in the presence or absence of 10 μg/ml anti-CD8 blocking
antibodies, numbers in the upper right corners indicate the percentage IFNγ producing
cells in the CD8+ T cell population after subtraction of background IFNγ production
(b1%). The effect of graded doses of anti-CD8 on low and high functional avidity GP33/
34-speciﬁc T cells (b) or NP396-speciﬁc T cells (c). Data are expressed as a percentage of
the maximum response observed in the absence of anti-CD8. P values were derived
using the two-tailed unequal-variance Student t-test. The data show the average±
standard deviation for 7 mice per group from 3 independent experiments.
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in Fig. 3 show that CD8+ T cells with high functional avidity are less
dependent on CD8/MHC Class I interactions than low functional
avidity T cells. Moreover, statistically signiﬁcant differences inresistance to anti-CD8 blockade were observed even under circum-
stances inwhich the differences in peptide sensitivity were as small as
3- to 5-fold between one T cell population and the other (e.g., GP33/
34). This indicates that anti-CD8 blockade is a useful method for
determining the functional attributes of T cell populations of the same
peptide speciﬁcity but which differ in terms of their overall sensitivity
to peptide stimulation.
Pharmacological inhibition of Src kinase activity
The anti-CD8 blocking antibody experiments provided evidence
supporting the theory that improvements in signal transduction
through the TcR may contribute to increased functional responsive-
ness in high avidity T cells. However, these studies fall short on
providing a molecular mechanism for the increase in TcR signaling
efﬁciency in highly responsive Tcell populations. The cytoplasmic tails
of CD4 and CD8 coreceptors associate with Src kinases such as Lck and
Fyn (Barber et al., 1989; Rudd et al., 1991, 1988; Veillette et al., 1988),
important signal transduction proteins involved in the initiation and
regulation of T cell activation (Bachmann et al., 1999; Latour and
Veillette, 2001; Palacios andWeiss, 2004; Salmond et al., 2009;Weiss,
1993; Zamoyska et al., 1989). To determine if high functional avidity
was associated with enhanced activity of Src kinase family members,
CD8+ T cells with a low or high functional avidity phenotype
(obtained at 5 or 8 days post-infection, respectively) were stimulated
with 1×10−5 M of the indicated peptide in the presence or absence of
graded doses of the Src kinase inhibitor, PP2 (4-Amino-5-(4-
chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) (Hanke et al.,
1996; Karni et al., 2003). To conﬁrm the results obtained with PP2, we
also tested a second Src kinase inhibitor, 7C-PP (Cyclopentyl-5-(4-
phenoxyphenyl)-7H-pyrrolo[2,3-d]pryrimidin-4-ylamine) (Arnold et
al., 2000; Burchat et al., 2000; Calderwood et al., 2002). Peptide-
speciﬁc CD8+ T cells of low functional avidity were signiﬁcantly more
susceptible to inhibition by PP2 or 7C-PP than Tcells of high functional
responsiveness (Fig. 4). In contrast, there was virtually no effect on
antigen-speciﬁc IFNγ production following incubationwith 10 μMPP3
(4-amino-7-phenylpyrazol[3,4-d]pyrmidine), a compound similar to
PP2 but without Src kinase-speciﬁc inhibitory properties (data not
shown). Similar to our anti-CD8 blockade experiments (Fig. 3), we
found signiﬁcant correlations between increased functional avidity
and increased resistance to pharmacological inhibition of T cell
activation (Fig. 4). In terms of peptide-speciﬁc T cell activation in
the presence of 1 μM PP2 or 2 μM PP2 (or 0.25 μM to 0.5 μM 7C-PP),
low avidity T cells obtained at 5 days post-LCMV infection were
consistently more susceptible to inhibition than high avidity T cells of
the same peptide speciﬁcity obtained at 8 days post-infection. This
result corresponds well with their peptide-speciﬁc thresholds of
activation (Fig. 2). PP2 is a potent and selective inhibitor of Src kinases
and is typically used at a concentration of 10 μM to completely
abrogate Src kinase activity. Not surprisingly, we found that T cell
activation was completely blocked at this dose, indicating that T cells
of high functional avidity were similar to T cells of low functional
avidity in that they rely heavily on Src kinase activity for effective
signal transduction and were unable to compensate for the loss of Src
kinase activity by utilizing other families of kinases. Similar to anti-
CD8 blockade, these pharmaceutical inhibitors of kinase activity
provide a useful tool for determining the quality/functional capacity
of T cell populations assessed at different stages of maturity.
Discussion
In these studies, we measured the frequency and functional
responsiveness of representative CD8+ T cell populations speciﬁc for
LCMV peptides: NP205, NP396, GP276 and the average response to
GP33/34 (an H-2Kb and H-2Db-restricted peptide) in C57BL/6 mice
during the course of acute LCMV infection. We found that
Fig. 4. Inhibition of Src kinase activity in T cells with a high or low functional avidity phenotype. The relationship between Src kinase activity and T cell responses to peptide
stimulationwas examined bymeasuring IFNγ production by CD8+ Tcells obtained at 5 or 8 days post-LCMV infection after stimulationwith 1×10−5M GP33/34 or NP396 peptide in
the presence or absence of the indicated concentrations of Src kinase inhibitor. Data are expressed as the percentage of the maximum response observed in the absence of Src kinase
inhibitors. P values were derived using the two-tailed unequal-variance Student t-test. The data show the average±standard deviation for 4 mice per group from 2 independent
experiments and are representative of 5 independent experiments.
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previously unrecognized shift in the dominance hierarchy during the
ﬁrst 8 days after acute viral infection. This is important because it
indicates that although naïve peptide-speciﬁc T cell precursor
frequencies can greatly inﬂuence the initial immunodominance
pattern, other factors must also be involved with determining the
ﬁnal dominance hierarchy that develops during acute LCMV infection.
Further analysis revealed that modiﬁcations in immunodominance
occurred independently from changes in functional avidity matura-
tion as measured by peptide dose–response curves and resistance to
inhibitionwith anti-CD8 blocking antibody or the pharmacological Src
kinase inhibitors, PP2 and 7C-PP. Together, these results indicate that
immunodominance is complex and although the naïve T cell
repertoire can inﬂuence initial immunodominance proﬁles, there is
much yet to be learned about the rules that govern the ﬁnal
immunodominance hierarchy elicited following acute viral infection.
Shifting patterns of T cell immunodominance have been observed
in several models of chronic viral infection including EBV (Woodberry
et al., 2005), SIV (Edwards et al., 2002), murine CMV (Munks et al.,
2006), MHV (Bergmann et al., 1999), and chronic LCMV infection
(Fuller and Zajac, 2003; Ou et al., 2001; van derMost et al., 2003,1996;
Wherry et al., 2003; Zajac et al., 1998). Following chronic LCMV
infection, it is striking that T cell responses directed against GP
epitopes are typically maintained whereas the dominant NP396-
speciﬁc T cell response is preferentially lost. This may be due to
differences in the kinetics (Probst et al., 2003) or quantity/duration
(Buchmeier and Zajac, 1999; Wherry et al., 2003) of NP versus GP
expression in vivo. For instance, LCMVNPmRNA is transcribed directly
from genomic RNA whereas GP mRNA synthesis occurs only after
genomic RNA is replicated. This results in more rapid expression of NP
mRNA compared to GP mRNA (Fuller-Pace and Southern, 1988) and in
turn, results in more rapid expression of viral peptides on the surfaceof infected cells (Probst et al., 2003). If the NP-speciﬁc T cells are
triggered more rapidly than GP-speciﬁc T cells, then it is possible that
cytokines [e.g., IFNγ (Rodriguez et al., 2002)] produced during the NP-
speciﬁc response may alter subsequent T cell responses to GP-speciﬁc
epitopes. It is unclear if this might account for the differences in
functional avidity maturation, but it is interesting that CD8+ T cell
responses against NP118, NP396, and NP205 undergo substantial
improvements in functional avidity during the early course of acute
LCMV infection whereas responses against GP33/34 and GP276
undergo much smaller changes in peptide sensitivity. In terms of
immunodominance, NP396-speciﬁc T cell responses outcompete the
combined GP33/34 response, but GP276 quickly outcompetes the
NP205-speciﬁc T cell response, indicating that simple differential
expression of GP and NP protein cannot be solely responsible for
determining immunodominance proﬁles.
Multiple factors are involved with the evolution of an antigen-
speciﬁc T cell response including early selection of high afﬁnity T cell
populations (Busch and Pamer, 1999; McHeyzer-Williams et al., 1999;
Savage et al., 1999; Zehn et al., 2009) followed by further changes in
functional responsiveness to peptide stimulation (Kroger and Alex-
ander-Miller, 2007a; Slifka and Whitton, 2001) that appear to involve
improvements in Src kinase activity (Fig. 4). There are several ways to
measure and compare the quality and functional attributes of antigen-
speciﬁc T cell populations. Peptide/MHC tetramers can be used to
measure structural avidity (i.e., the binding of the TcR to peptide/MHC
molecules) but this does not always predict functional attributes since
chronically infected mice can have LCMV-speciﬁc T cells that clearly
bind peptide/MHC but remain unresponsive to peptide stimulation
(Wherry et al., 2003; Zajac et al., 1998). Another approach is to
measure peptide sensitivity or “functional avidity” by stimulating T
cells with graded doses of peptide antigen and determining their
ability to respond to low levels of antigenic stimulation. Functional
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structural avidity and functional responsiveness. In our studies, we
used peptide-induced IFNγ production to measure functional avidity
but measurements of other cytokines (e.g., TNFα, IL-2, etc.) or
cytolytic activity against peptide-coated targets may also be
employed. In a previous work, we have shown that functional avidity
based on IFNγ production is similar to that observed for TNFα or CTL
activity following acute LCMV infection (Slifka and Whitton, 2001). T
cells with a high functional avidity phenotype have been shown to be
more protective against viral infection than T cells of a low functional
avidity phenotype (Alexander-Miller, 2005; Alexander-Miller et al.,
1996). Improvements in functional avidity can also occur in TcR
transgenic T cells (Kroger and Alexander-Miller, 2007a; Slifka and
Whitton, 2001). We found up to a 10-fold increase in functional
avidity in GP33-speciﬁc T cells from LCMV-infected P14 mice at 8 days
post-infection (Slifka and Whitton, 2001) and in subsequent studies
with P14 mice, P14 mice crossed with Rag−/− mice, or in adoptive
transfer experiments we found a more modest 3- to 4-fold improve-
ment in functional avidity by 8 days post-infection (data not shown)
and this is similar to the GP33/34-speciﬁc T cell responses observed in
wild type C57BL/6 mice (Fig. 2b). This indicates that although the
studies described in this report represent the combined average of the
GP33 (H-2Db)-speciﬁc and GP34 (H-2Kb)-speciﬁc CD8+ T cell
responses, the results appear to be similar to that observed when
only GP33 (H-2Db)-speciﬁc T cells are examined. An elegant study
using mice with Lck expressed under an inducible promoter has
clearly shown that Lck is not required for GP33-speciﬁc memory T cell
responsiveness to peptide antigen following acute LCMV infection
(Tewari et al., 2006). One explanation for these ﬁndings is that it is
possible that Lck may not be involved with functional responsiveness
in T cell populations that do not undergo a large degree of functional
avidity maturation. It will be important to learn whether Lck is also
not required for NP396-speciﬁc T cell responsiveness to peptide
antigen (i.e., T cells that undergo large changes in functional avidity)
or if these T cell populations differ with respect to their use of Lck or
perhaps other Src kinases. Interestingly, NP396-speciﬁc T cell
responses in C57BL/6mice underwent the largest degree of functional
avidity maturation during primary infection (Fig. 2b) and become the
most dominant virus-speciﬁc T cell population observed following re-
infection (Murali-Krishna et al., 1998; Tebo et al., 2005). Similar shifts
in immunodominance are observed following acute infection with
inﬂuenza virus; during the primary response, the PA224-speciﬁc and
NP366-speciﬁc T cell responses are codominant whereas following
secondary infection, the T cell response is sharply dominated by
NP366-speciﬁc CD8+ Tcells (Belz et al., 2001, 2000). It is yet unclear if
this shift in immunodominance during secondary infection is due, at
least in part, to improved functional avidity within a peptide-speciﬁc
T cell population that develops during the primary immune response
or if it may be due to a variety of other factors such as T cell
precursor frequency and competition during re-infection (La Gruta
et al., 2006a,b).
We have previously demonstrated that resistance to anti-CD8
blocking antibodies is a simple and effective approach for
distinguishing between peptide-speciﬁc T cell populations with
low or high avidity (Slifka and Whitton, 2001) (Fig. 3). In these
current studies, we have broadened this type of functional analysis
to include peptide stimulation in the presence or absence of Src
kinase inhibitors such as PP2 and 7C-PP (Fig. 4). These pharmaco-
logical inhibitors of signal transduction provide a mechanistic
approach to determining the functional capacity of virus-speciﬁc T
cells. In this regard, we found that T cells obtained at 8 days post-
LCMV infection (representing a high functional avidity population)
were signiﬁcantly more resistant to PP2 and 7C-PP inhibition than T
cells examined at 5 days post-LCMV infection (representing a low
functional avidity population). By using two distinct pharmacologi-
cal inhibitors of Src kinase activity, PP2 and 7C-PP, we are able tomeasure T cell function by two independent biochemical
approaches. In previous studies, we found changes in Lck expression
that were linked to increased T cell responsiveness based on
intracellular staining with polyclonal anti-Lck antibodies (Slifka and
Whitton, 2001). However, similar to another study (La Gruta et al.,
2006a,b), we did not ﬁnd substantial differences in the total cellular
expression of T cell-associated Src kinases, Lck or Fyn by ﬂow
cytometry using monoclonal antibodies speciﬁc to these antigens
(data not shown). These results do not necessarily rule out a role for
improved signal transduction in the development of improved
functional avidity as it is possible that changes in subcellular
localization and/or the activation state of these kinases, rather than
total cellular levels, are more important for improved T cell signaling
through the TcR. Previous studies have indicated a higher associa-
tion of Lck with the cytoplasmic tail of CD8 molecules following
LCMV infection (Bachmann et al., 1999) and this may represent at
least one mechanism responsible for improved T cell responses and
functional avidity maturation observed during the early stages of
acute viral infection. In addition to standard peptide dose–response
curves and anti-CD8 antibody blockade, we show here that
exposure to pharmacological Src kinase inhibitors such as PP2 and
7C-PP can be used to characterize T cell function and distinguish
between high and low avidity T cell populations of the same antigen
speciﬁcity. This may be a useful approach for assessing the quality of
vaccine-induced CD8+ T cell populations.Conclusions
The results of this study indicate that shifting immunodominance
proﬁles are not limited to chronic LCMV infection and instead can be
observed during the very early stages of acute LCMV infection as well.
Our studies focused on T cell immunodominance in the spleen (a
major site of LCMV infection) and it is possible that the rules for
immunodominance differ in other anatomical sites. These early
changes in CD8+ T cell immunodominance observed in the spleen
suggest that the naïve T cell precursor frequency is not the sole factor
involved with determining the immunodominance hierarchy since
the relative magnitude of different peptide-speciﬁc T cell populations
continue to evolve during the ﬁrst 4–8 days after infection. Analysis of
functional avidity maturation of four representative peptide-speciﬁc T
cell populations indicated that immunodominance proﬁles evolved
independently of changes in peptide sensitivity. Interestingly, not all T
cell populations undergo measurable functional avidity maturation
and T cells speciﬁc for the LCMV glycoprotein (GP) undergo much less
avidity maturation than T cells speciﬁc for the LCMV nucleoprotein
(NP). This may have further implications on T cell immunobiology
since chronic LCMV infection is known to delete or functionally
“exhaust” NP-speciﬁc T cells over GP-speciﬁc T cell populations.
Together, our results demonstrate that immunodominance is not
static during acute LCMV infection and instead evolves quickly during
the early stages of infection before reaching a stable pattern of
immunodominance that is maintained during the memory phase of
the antiviral immune response.Methods
Mice and virus
C57BL/6 mice were purchased from Jackson Laboratory (Bar
Harbor, Maine), C57BL/6.Thy1aIgHaGpia mice were bred at OHSU
and used interchangeably with C57BL/6 mice. Animals were infected
intraperitoneally with 2×105 PFU LCMV-Armstrong (Arm-53b) at 5–
12 weeks of age. The Oregon Health & Science University IACUC
committee approved all animal protocols.
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HPLC-puriﬁed (N95% pure) GP33/34 (KAVYNFATM), NP396
(FQPQNGQFI), GP276 (SGVENPGGYCL), and NP205 (YTVKYPNL)
peptides were purchased from Alpha Diagnostic International (San
Antonio, TX), Aves Labs (Tigard, OR) and Sigma Genosys (St Lois, MO).
Anti-CD8 blocking antibody (clone 53-6.7) was purchased from
PharMingen (San Diego, CA). Src kinase inhibitors, PP2 (4-Amino-5-
(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine) (Hanke et
al., 1996; Karni et al., 2003) and 7C-PP (Cyclopentyl-5-(4-phenox-
yphenyl)-7H-pyrrolo[2,3-d]pryrimidin-4-ylamine) (Arnold et al.,
2000; Burchat et al., 2000; Calderwood et al., 2002), were purchased
from EMDbiosciences (Calbiochem, San Diego, CA) and Sigma-Aldrich
(St Lois, MO) respectively, and dissolved at 5 mM in DMSO.
Direct ex vivo stimulation and intracellular staining
Peptide stimulation and intracellular cytokine staining was per-
formed as described previously (Raue and Slifka, 2007). In summary,
single cell splenocyte suspensions were stimulated with the indicated
concentrations of peptide in RPMI supplementedwith 5% FBS (Hyclone,
Logan, UT), 20 mM HEPES, L-glutamine, antibiotics and 2 μg/ml
Brefeldin A (Sigma) at 37 °C, 6% CO2 for 6 h. After stimulation, cells
were stained overnight with anti-CD8α (clone 5H10, Caltag, Burlin-
game, CA) and ﬁxed in PBS+2% formaldehyde the next morning. After
staining with anti-IFNγ (Caltag) in Permwash (0.1% saponin (Sigma),
0.1% NaN3 (Sigma), 2% FBS in PBS) at 4 °C cells were washed with
Permwash and PBS+1% FCS and resuspended in PBS+2% formalde-
hyde for analysis. Data was acquired on a FACSCalibur or LSR-2 and
analyzed using CellQuest (Becton Dickinson, San Jose, CA) or FlowJo
software (Treestar, Ashland, OR). Non-speciﬁc IFNγ production after
incubationwithmedium alonewas subtracted to yield the frequency of
virus-speciﬁc IFNγ+CD8+ Tcells. For inhibition experiments, cellswere
pre-incubated with anti-CD8 blocking antibody (clone 53-6.7 used at
4 °C) or the Src kinase inhibitors, PP2 or 7C-PP (at 37 °C) for 20minprior
to addition of peptide plus Brefeldin A and incubated at 37 °C for 6 h.
Statistics
Statistical signiﬁcance was determined using a two-tailed Stu-
dent's t-test with unequal variance (Excel, Microsoft, WA). P values of
≤0.05 were considered statistically signiﬁcant.
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